Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1956 Sep;35(9):1055–1066. doi: 10.1172/JCI103351

PLASMA REGRESSION, DISTRIBUTION AND EXCRETION OF RADIOMERCURY IN RELATION TO DIURESIS FOLLOWING THE INTRAVENOUS ADMINISTRATION OF Hg203 LABELLED CHLORMERODRIN TO THE DOG 1

R R M Borghgraef 1,2, R H Kessler 1,3, R F Pitts 1, M E Parks 1, W Van Woert 1, M B MacLeod 1
PMCID: PMC441680  PMID: 13367202

Full text

PDF
1055

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARRETT M. J. Chronic and acute effects of mercuhydrin and thiomerin on renal tubular function in the dog. J Pharmacol Exp Ther. 1950 Dec;100(41):502–510. [PubMed] [Google Scholar]
  2. BORGHGRAEF R. R., PITTS R. F. The distribution of chlormerodrin (neohydrin) in tissues of the rat and dog. J Clin Invest. 1956 Jan;35(1):31–37. doi: 10.1172/JCI103249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BURCH G., RAY T., THREEFOOT S., KELLY F. J., SVEDBERG A. The urinary excretion and biologic decay periods of radiomercury labeling a mercurial diuretic in normal and diseased man. J Clin Invest. 1950 Sep;29(9):1131–1138. doi: 10.1172/JCI102350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GREIF R. L., SULLIVAN W. J., JACOBS G. S., PITTS R. F. Distribution of radiomercury administered as labelled chlormerodrin (neohydrin) in the kidneys of rats and dogs. J Clin Invest. 1956 Jan;35(1):38–43. doi: 10.1172/JCI103250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GROSSMAN J., WESTON R. E., LEHMAN R. A., HALPERIN J. P., ULLMANN T. D., LEITER L. Urinary and fecal excretion of mercury in man following administration of mercurial diuretics. J Clin Invest. 1951 Nov;30(11):1208–1220. doi: 10.1172/JCI102540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kennedy J. A., Millikan G. A. A micro blood volume method using a blue dye and photocell. J Physiol. 1938 Aug 15;93(3):276–284. doi: 10.1113/jphysiol.1938.sp003639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. MILNOR J. P. Binding of the mercury of an organic mercurial diuretic by plasma proteins. Proc Soc Exp Biol Med. 1950 Oct;75(1):63–65. doi: 10.3181/00379727-75-18101. [DOI] [PubMed] [Google Scholar]
  8. MILNOR P., BURCH G. Considerations of renal, hepatic, and extremital arteriovenous differences in concentration of radiomercury of a mercurial diuretic. J Clin Invest. 1950 Jan;29(1):72–86. doi: 10.1172/JCI102237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. PITTS R. F., SARTORIUS O. W. Mechanism of action and therapeutic use of diuretics. J Pharmacol Exp Ther. 1950 Apr;98(42):161–226. [PubMed] [Google Scholar]
  10. Threefoot S. A., Ray C. T., Burch G. E., Cronvich J. A., Milnor J. P., Overman W., Gordon W. CONCENTRATION-TIME COURSE IN THE PLASMA OF MAN OF RADIOMERCURY INTRODUCED AS A MERCURIAL DIURETIC. J Clin Invest. 1949 Jul;28(4):661–670. doi: 10.1172/JCI102116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. WESTON R. E., GROSSMAN J., LEHMAN R. A., ULLMANN T. D., HALPERIN J. P., LEITER L. Renal extraction and excretion of mercury in man following intravenously administered mercurial diuretics. J Clin Invest. 1951 Nov;30(11):1221–1227. doi: 10.1172/JCI102541. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES